SES AI SES Contingent Consideration Liability (Non-Current)

Contingent Consideration Liability (Non-Current) at other companies

ANI PharmaceuticalsANIP

$9.25M-46.9%

Steven MaddenSHOO

$15.27M+397%

KadantKAI

$2M—

LivaNovaLIVN

$43.14M-49.3%

CBIZCBZ

$4.38M-77.3%

uniQureQURE

$17.03M+35.6%

Other financials

Income statement

See full

Revenue$6.7M+15.8%

Gross profit$1.2M-73.3%

Operating income-$17.9M+23.2%

Net income-$12.1M+2.7%

EPS (diluted)-$0.040.0%

Balance sheet

See full

Cash & equivalents$46.9M-16.3%

Total debt$7.7M-18.9%

Total equity$203.2M-24.7%

Total assets$253.5M-17.1%

Cash flow

See full

Operating cash flow-$19.8M+13.3%

CapEx$330.0K-64.0%

Free cash flow-$20.1M+15.2%

Valuation

See full

Market cap$325.08M+5.5%

Enterprise value$285.86M+9.3%

P/S14.8×-27.2×

Profitability

See full

Gross margin36.3%-39.1pp

Operating margin-352.3%-153pp

Net margin-331.7%-142pp

FCF margin-262.8%-115pp

Returns & leverage

See full

Return on equity-30.7%-0.7pp

Debt / equity0×0.0×

Current ratio6.9×-8.8×

Where this comes from

Reported directly by SES AI in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent.

The official record: SES AI’s 10-Q, filed April 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about SES AI's contingent consideration liability (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SES AI's contingent consideration liability (non-current)?: SES AI (SES) reported contingent consideration liability (non-current) of $7.68M in Q4 2025.